Senokot Tablet
FDA Label NDC 67618-300

2 label sections · Submitted to the FDA by Atlantis Consumer Healthcare, Inc. · Indications, Dosage, Usage, and Precautions

Structured Product Label

The following Structured Product Label (SPL) was submitted to the FDA by Atlantis Consumer Healthcare, Inc. for the product Senokot (NDC 67618-300). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.

This specific version of the label includes detailed information regarding purpose, package label.principal display panel, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.

Purpose

Laxative

Package Label.Principal Display Panel

50 Tablets
NDC 67618-300-50

50 Tablets Label (Label50)

50 Tablets Label (Label50)

50 Tablets Leaflet (Leaflet50)

50 Tablets Leaflet (Leaflet50)

50 Tablets Carton (Carton50)

50 Tablets Carton (Carton50)

100 Tablets
NDC 67618-300-10

100 Tablets Label (Label100)

100 Tablets Label (Label100)

100 Tablets Leaflet (Leaflet100)

100 Tablets Leaflet (Leaflet100)

100 Tablets Carton (Carton100)

100 Tablets Carton (Carton100)

* Please review the disclaimer below.